MRC Epidemiology Unit

 

Changes in behaviors after diagnosis of type 2 diabetes and 10-year incidence of cardiovascular disease and mortality.

Strelitz J, Ahern AL, Long GH, Boothby CE, Wareham NJ, and Griffin SJ

Cardiovascular diabetology. May 2019

(DOI : 10.1186/s12933-019-0902-5)

---

Moderate weight change following diabetes diagnosis and 10 year incidence of cardiovascular disease and mortality.

Strelitz J, Ahern AL, Long GH, Hare MJL, Irving G, Boothby CE, Wareham NJ, and Griffin SJ

Diabetologia. Dec 2018

(DOI : 10.1007/s00125-019-4886-1)

---

How good are GPs at adhering to a pragmatic trial protocol in primary care? Results from the ADDITION-Cambridge cluster-randomised pragmatic trial.

Laxy M, Wilson ECF, Boothby CE, and Griffin SJ

BMJ Open. Jun 2018

(DOI : 10.1136/bmjopen-2016-015295)

---

Incremental Costs and Cost Effectiveness of Intensive Treatment in Individuals with Type 2 Diabetes Detected by Screening in the ADDITION-UK Trial: An Update with Empirical Trial-Based Cost Data.

Laxy M, Wilson ECF, Boothby CE, and Griffin SJ

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. Sep 2016

(DOI : 10.1016/j.jval.2017.05.018)

---

Medication burden in the first 5 years following diagnosis of type 2 diabetes: findings from the ADDITION-UK trial cohort.

Black JA, Simmons RK, Boothby CE, Davies MJ, Webb D, Khunti K, Long GH, and Griffin SJ

BMJ open diabetes research & care. Dec 2014

(DOI : 10.1136/bmjdrc-2014-000075)

---

Change in cardio-protective medication and health-related quality of life after diagnosis of screen-detected diabetes: Results from the ADDITION-Cambridge cohort.

Black JA, Long GH, Sharp SJ, Kuznetsov L, Boothby CE, Griffin SJ, and Simmons RK

Diabetes Research and Clinical Practice. Nov 2014

(DOI : 10.1016/j.diabres.2015.04.013)

---